Facing headwinds including higher spending on patient care, UnitedHealth Group executives on Tuesday forecast a conservative growth projection for next year, prompting investors to send the stock lower.
The Minnetonka-based health care giant announced it now expects at most around $30 per share in earnings next year, about half of the expected growth rate, BofA Securities noted in a research report. Yet analysts remain bullish on UnitedHealth Group, given the company’s ability to navigate the insurance environment and the expectation it can gain share in the Medicare Advantage market next year.
UnitedHealth Group stock sank more than 8% after third-quarter earnings results were released Tuesday.
Chief Executive Andrew Witty said the outlook was driven by factors that primarily hurt its health insurance business.
A reduction in Medicare funding, previously disclosed, will continue to challenge the company’s insurance division, UnitedHealthcare. Witty added that state payment rates received by the company do not match use of medical services by its Medicaid patients.
UnitedHealthcare says it has also seen an uptick in the use of expensive medications across both Medicare and Medicaid. The company is a large vendor to both of the government health insurance programs.
“As a result, we anticipate stepping out for 2025 more conservatively than is typical,” Witty said, referring to financial guidance for next year. “We will be prudent in an initial early view.”
The CEO’s commentary came during an earnings call when UnitedHealth Group executives detailed how medical costs rose during the third quarter. The company’s percentage of premium dollars spent on medical care — known as the “medical loss ratio” — came in at 85.2% for the third quarter, a rise from 85.1% during the previous three months and 82.3% during the same period last year.